BOLD Longevity Growth Fund
BOLD Longevity Growth is a leading global longevity fund investing in frontier biotechnologies that target the root causes of age-related diseases and aim to extend healthy human lifespan. The fund specializes in growth and scaling stages, focusing on the intersection of longevity, biotech, and artificial intelligence, with a mission to make these technologies affordable and accessible. They invest in platform technologies that offer significant improvements in efficiency and safety, reshaping medical practice. Their investment strategy targets companies focusing on the root causes of aging and diseases, often co-investing with major biotech VC funds and large pharmaceutical companies. The team possesses deep expertise in aging biology and longevity investments, with prior investment track records in areas like gene editing, AI-powered medical devices, and AI cancer detection.
BOLD Longevity Growth Fund
BOLD Longevity Growth is a leading global longevity fund investing in frontier biotechnologies that target the root causes of age-related diseases and aim to extend healthy human lifespan. The fund specializes in growth and scaling stages, focusing on the intersection of longevity, biotech, and artificial intelligence, with a mission to make these technologies affordable and accessible. They invest in platform technologies that offer significant improvements in efficiency and safety, reshaping medical practice. Their investment strategy targets companies focusing on the root causes of aging and diseases, often co-investing with major biotech VC funds and large pharmaceutical companies. The team possesses deep expertise in aging biology and longevity investments, with prior investment track records in areas like gene editing, AI-powered medical devices, and AI cancer detection.